|
Forecast Period
|
2026-2030
|
|
Market Size (2024)
|
USD 178.89 Million
|
|
Market Size (2030)
|
USD 258.25 Million
|
|
CAGR (2025-2030)
|
6.23%
|
|
Fastest Growing Segment
|
Monofocal IOL
|
|
Largest Market
|
Kanto
|
Market Overview
Japan Intraocular Lenses Market was valued at USD
178.89 Million in 2024 and is anticipated to project impressive growth in the
forecast period with a CAGR of 6.23% through 2030. The
Japan Intraocular Lenses (IOLs) Market is primarily driven by several factors,
including the country's aging population, which contributes to a higher
prevalence of age-related eye conditions such as cataracts. Increasing
awareness and adoption of advanced surgical procedures, coupled with
technological advancements in IOL materials and designs, are also significant
drivers. These advancements enhance the safety, efficacy, and outcomes of
cataract surgeries, thereby expanding the market. Favorable healthcare policies
and reimbursement schemes for cataract surgeries support patient access to
premium IOLs, driving market growth further. The evolving preferences of
patients and healthcare providers towards premium IOLs that offer improved
visual outcomes and reduced dependency on glasses also contribute to the
market's expansion in Japan.
Key Market Drivers
Aging Population and Cataract Surgery Demand
Japan is currently experiencing one of the most
pronounced demographic shifts globally, characterized by a rapidly aging
population. This demographic trend is profoundly impacting the prevalence of
age-related eye conditions, with cataracts emerging as a prevalent issue among
elderly individuals. Cataracts develop gradually over time, clouding the lens
of the eye and impairing vision. As the Japanese population ages, there is a
corresponding increase in the incidence of cataracts. According to an
article titled, “Annual trends of ophthalmic surgeries in Japan’s super-aged
society, 2014–2020: a national claims database study”, between fiscal years
2014 and 2018, the total number of cataract surgeries stabilized around 1.45
million cases, showing a slight rise to nearly 1.6 million in fiscal year 2019.
However, it reverted to 1.45 million in fiscal year 2020 amidst the onset of
the COVID-19 pandemic in Japan. Analyzing age-specific data reveals consistent
surgery rates up to the age of 70 from fiscal years 2014 to 2019, with an
uptick in surgeries for those over 70 years old. In fiscal year 2020, there was
a notable decline in surgeries for patients aged over 60 years.
Cataract surgery remains the primary treatment for
restoring vision impaired by cataracts. During these surgical procedures, the
natural lens affected by the cataract is removed and replaced with an
artificial intraocular lens (IOL). IOLs play a crucial role in these
interventions by effectively restoring clarity of vision and improving overall
visual acuity. Given the aging population's expanding proportion, the demand
for cataract surgeries and subsequent IOL implants is steadily rising in Japan.
This demographic shift ensures a continuous and growing demand for IOLs in
Japan's healthcare system. The necessity for surgical intervention to address
age-related eye conditions underscores the critical role of IOLs in maintaining
and enhancing the quality of life for the elderly population. As such, the
Japan Intraocular Lenses Market is poised for sustained growth, driven by the
increasing need for effective vision correction solutions among the aging
demographic.
Technological Advancements
Continuous advancements in intraocular lens (IOL)
technology have revolutionized the landscape of cataract surgery and refractive
lens exchange procedures, significantly improving surgical outcomes and patient
satisfaction in Japan and globally. One of the pivotal advancements lies in the
evolution of IOL materials. Hydrophobic and hydrophilic acrylic materials have
emerged as preferred choices due to their biocompatibility, optical clarity,
and ability to minimize post-operative complications such as inflammation and
posterior capsular opacification (PCO). The development of multifocal and toric
designs has been instrumental in addressing various vision correction needs.
Multifocal IOLs enable clear vision at multiple distances, reducing dependence
on glasses for activities such as reading and driving. Meanwhile, toric IOLs
correct astigmatism, offering patients improved visual acuity and reducing
optical aberrations. In June 2023, BVI, known for its rapid growth in the
field of surgical ophthalmology, announced the official introduction of
FINEVISION HP in Japan. This hydrophobic trifocal IOL marks a significant
advancement in trifocal lens technology, being the first of its kind to provide
cataract patients with high-quality vision at all distances, without
glistening. The product has generated considerable excitement and interest,
prompting BVI Japan to receive initial orders for FINEVISION HP ahead of its
official launch.
These technological innovations not only enhance
surgical precision and efficiency but also contribute to improved patient
outcomes and overall satisfaction. Surgeons in Japan are increasingly adopting
these advanced IOLs to cater to diverse patient needs, thereby driving market
growth. The ability of modern IOLs to provide tailored solutions for
astigmatism, presbyopia, and other refractive errors underscores their role in
meeting the evolving expectations of patients seeking optimal visual clarity
and quality of life post-surgery. As a result, the Japan Intraocular Lenses
Market continues to expand with ongoing advancements in IOL technology paving
the way for enhanced surgical experiences and patient care.
Rising Disposable Income
Increasing disposable incomes among Japanese
consumers have played a significant role in shaping the demand landscape for
advanced healthcare solutions, particularly in the realm of intraocular lenses
(IOLs). As disposable incomes rise, there is a corresponding increase in the
willingness of patients to invest in premium IOLs that promise superior visual
outcomes and enhanced convenience post-surgery. Premium IOLs are designed with
advanced optical technologies and materials that offer several advantages over
traditional monofocal lenses. These lenses often incorporate features such as
multifocality, extended depth of focus, or correction for astigmatism, allowing
patients to achieve clearer vision at various distances without the need for
glasses or contact lenses. For individuals with higher disposable incomes, the
appeal of these premium IOLs lies in their ability to provide enhanced visual
quality and reduce dependency on corrective eyewear, thereby improving overall
quality of life.
The preference for premium IOLs among affluent
consumers reflects a broader trend towards prioritizing health and wellness
expenditures. Patients are increasingly willing to invest in medical treatments
and technologies that offer long-term benefits and improve daily living. This
economic factor not only expands the market for premium IOLs in Japan but also
incentivizes manufacturers and healthcare providers to innovate and introduce
advanced lens options that cater to diverse patient needs and preferences.
Preference for Minimally Invasive Surgery
The preference for minimally invasive surgical
techniques such as small incision cataract surgery (SICS) and
phacoemulsification has significantly contributed to the increasing adoption of
intraocular lenses (IOLs) in Japan. These advanced surgical methods have
revolutionized cataract surgery by offering numerous advantages over
traditional approaches, including quicker recovery times, reduced risk of
complications, and enhanced patient comfort during and after the procedure. SICS
involves making a smaller incision compared to traditional extracapsular
cataract extraction (ECCE), which minimizes trauma to the eye and accelerates
healing. Phacoemulsification, on the other hand, utilizes ultrasound energy to
break up the cataract lens before suctioning it out through a tiny incision.
Both techniques require the implantation of an IOL to replace the natural lens
removed during surgery, thereby restoring clear vision.
The compatibility of IOLs with these modern
surgical techniques is crucial for optimizing surgical outcomes and patient
satisfaction. Advanced IOL designs, such as multifocal, toric, and extended
depth of focus lenses, are tailored to meet the specific visual needs of
patients undergoing minimally invasive cataract surgery. These lenses not only
correct cataracts but also address conditions like astigmatism and presbyopia,
allowing patients to achieve improved visual acuity without reliance on glasses
or contact lenses post-surgery. The growing adoption of minimally invasive
surgical techniques in Japan reflects a broader global trend towards enhancing
surgical precision, reducing recovery times, and improving overall patient
outcomes. As these techniques become more widely practiced and preferred by
both patients and healthcare providers, the demand for high-quality IOLs that
complement these advancements continues to rise. Manufacturers in the Japan
Intraocular Lenses Market are therefore focused on developing innovative IOL
technologies that integrate seamlessly with modern surgical methods, thereby
driving the evolution and expansion of the market while meeting the increasing
expectations of patients for optimal visual outcomes.
Download Free Sample Report
Key Market Challenges
Regulatory Compliance and Approval Processes
Navigating Japan's stringent regulatory environment
poses a substantial challenge for manufacturers operating in the Intraocular
Lenses (IOLs) market. The country's regulatory framework for medical devices,
including IOLs, is characterized by rigorous standards aimed at ensuring
patient safety and product efficacy. These standards are set by the
Pharmaceuticals and Medical Devices Agency (PMDA), which oversees the approval
and regulation of medical devices in Japan.
One of the primary hurdles faced by manufacturers
is the lengthy and meticulous approval process required for new IOL products.
The PMDA mandates thorough clinical trials and comprehensive documentation to
demonstrate the safety and effectiveness of IOLs before they can be approved
for commercialization. This process involves multiple stages of review,
including pre-market approval (PMA) and post-market surveillance, which can
significantly delay the market entry of new products compared to other regions
with less stringent requirements. The regulatory landscape in Japan differs
from that of other countries, necessitating manufacturers to adapt their
strategies and invest additional resources in compliance. This includes
conducting specific studies tailored to meet Japanese regulatory standards,
which may differ from those required by the U.S. Food and Drug Administration
(FDA) or the European Medicines Agency (EMA). The need to navigate these
distinct regulatory pathways can prolong the development timeline and increase
costs associated with obtaining market approval.
Cost and Affordability
Cost is a critical factor influencing the adoption
of IOLs in Japan. While the country boasts a high standard of healthcare, the
costs associated with premium IOLs, such as multifocal or toric lenses, can be
prohibitive for some patients. The reimbursement policies under Japan's
national health insurance system may not fully cover the expenses of advanced
IOL technologies, leading to disparities in access based on socioeconomic
status. This affordability issue poses a challenge for manufacturers aiming to
penetrate the broader market while maintaining profitability.
Key Market Trends
Increasing Prevalence of Myopia
Beyond cataract surgery, the Japan Intraocular
Lenses (IOLs) Market is witnessing a notable expansion in applications due to
the rising prevalence of myopia among the younger population. Myopia, or
nearsightedness, has become increasingly prevalent in Japan, driven by factors
such as lifestyle changes, prolonged near work activities, and environmental
factors. This demographic shift is influencing the demand for IOLs not only as
a solution for cataract treatment but also as a viable option for refractive
correction among younger individuals.
In particular, phakic IOLs are gaining traction as
a preferred method for correcting myopia. Unlike traditional refractive
surgeries such as LASIK (laser-assisted in situ keratomileusis), which reshape
the cornea, phakic IOLs are implanted in front of or behind the iris while
leaving the natural lens intact. This approach provides a reversible
alternative for individuals seeking to reduce dependence on glasses or contact
lenses without permanently altering the corneal structure. The appeal of phakic
IOLs lies in their ability to correct higher degrees of myopia with predictable
outcomes and minimal impact on corneal biomechanics. This makes them
particularly suitable for patients with thin corneas or other conditions that
preclude them from undergoing LASIK or other corneal refractive procedures. Advancements
in phakic IOL technology have led to the development of various designs,
including iris-fixated, angle-supported, and posterior chamber models, which
offer surgeons flexibility in addressing different patient needs and anatomical
considerations.
Strategic Partnerships and Collaborations
Collaborations between multinational intraocular
lens (IOL) manufacturers and local distributors in Japan are pivotal in
advancing the country's access to cutting-edge IOL technologies and products.
These partnerships bring together the global expertise of multinational
manufacturers in IOL research, development, and production with the local
market knowledge and distribution networks of Japanese distributors.
One of the primary benefits of these collaborations
is the introduction of innovative IOL products into the Japanese market.
Multinational manufacturers often leverage their extensive research and
development capabilities to create next-generation IOLs that incorporate
advanced materials, designs, and technologies. These innovations cater to a
wide spectrum of patient needs, including those requiring multifocal, toric, or
extended depth-of-focus IOLs for enhanced visual outcomes. Furthermore,
partnerships with local distributors ensure that these innovative IOLs are
efficiently marketed and distributed across Japan. Distributors play a crucial
role in navigating the complex regulatory landscape, ensuring compliance with
Japanese standards, and facilitating market entry for new IOL products. They
also provide essential support in terms of sales, marketing, and customer
education, helping healthcare professionals and patients alike understand the
benefits and optimal use of advanced IOL technologies.
Segmental Insights
Product Insights
Based on the Product, the
Japan market for intraocular lenses (IOLs) is predominantly led by monofocal
IOLs, which commanded the largest share of revenue in 2022. This leadership can
be attributed to several key factors. Monofocal IOLs are favored by many
ophthalmologists in Japan due to their established efficacy in treating
cataracts. These lenses are designed with a single focal point, typically used
during cataract surgery to correct either distance vision myopia or near vision
hyperopia. The straightforward nature and reliability of monofocal IOLs have
cemented their popularity among both healthcare providers and patients across
Japan. The widespread coverage of monofocal IOLs by insurance providers in
Japan enhances their accessibility and affordability for patients. This
supportive reimbursement framework has encouraged healthcare providers to adopt
monofocal IOL technology more readily, thus bolstering market expansion.
The presence of leading
global industry players such as Alcon, Bausch + Lomb, and Johnson & Johnson
Vision also plays a pivotal role in the dominance of monofocal IOLs in Japan.
These companies have established strong footholds in the Japanese market,
leveraging their expertise in manufacturing and distributing monofocal IOLs.
Their extensive sales networks, commitment to innovation, and continuous
product advancements have further solidified the market position of monofocal
IOLs. Japan's aging population and the increasing incidence of cataracts have
significantly propelled the demand for monofocal IOLs. As the population ages,
the prevalence of cataracts continues to rise, underscoring the need for
effective and dependable IOL solutions. Monofocal IOLs, backed by their
long-standing track record and widespread adoption, have successfully met this
escalating demand.
Material Insights
Based on Material, the
Japan intraocular lens (IOL) market is dominated by polymethylmethacrylate
(PMMA) lenses, which have maintained a strong position in the market despite
the emergence of newer lens materials, such as silicone and hydrophobic
acrylic. PMMA, the first material used for IOLs, has remained a popular choice
among Japanese ophthalmologists due to its well-established track record and
several key advantages. PMMA lenses are known for their excellent
biocompatibility and long-term stability within the eye. The material's rigid
structure and high refractive index of 1.49 provide superior optical clarity,
allowing for a broad spectrum of light transmission. This optical performance
has made PMMA lenses a reliable choice for cataract surgery patients in Japan.
PMMA lenses are relatively
cost-effective compared to some of the newer IOL materials, making them more
accessible to a wider range of patients in the Japanese healthcare system. The
favorable reimbursement policies in Japan, which often cover the costs of PMMA
lenses, have further contributed to their widespread adoption. Another factor
contributing to the dominance of PMMA lenses in the Japanese market is the strong
presence of global manufacturers, such as Contamac, that have established a
significant foothold in the country. These companies have leveraged their
expertise in PMMA lens production and distribution, ensuring a consistent
supply and availability of the material to healthcare providers.
Download Free Sample Report
Regional Insights
The Kanto region, which includes the Greater Tokyo
Area, has emerged as the dominant force in the Japan intraocular lens (IOL)
market, accounting for the largest market share. This regional dominance can be
attributed to several key factors. The Kanto region is home to a significant
concentration of leading healthcare institutions and medical facilities in
Japan. The region boasts a high density of renowned hospitals, specialized
clinics, and advanced medical research centers that are at the forefront of
cataract surgery and IOL implantation. These healthcare providers in the Kanto
region have been quick to adopt the latest IOL technologies and techniques,
driving the demand for cutting-edge IOL devices.
The Kanto region, particularly the Tokyo
metropolitan area, has a large and aging population, which has contributed to
the region's prominence in the IOL market. As the population ages, the
prevalence of cataracts has increased, fueling the demand for IOL implantation
procedures in the Kanto region. The availability of advanced IOL technologies
and skilled ophthalmologists has made the region a preferred destination for
cataract patients seeking high-quality care. The concentration of major IOL
manufacturers and distributors in the Kanto region has also been a significant
factor in the region's dominance. Many of the leading global and domestic
players in the IOL market, such as Alcon, Bausch + Lomb, and Johnson &
Johnson Vision, have their headquarters or major production facilities located
in the Kanto region. This proximity to the manufacturing and distribution hubs
has enabled healthcare providers in the Kanto region to have easier access to
the latest IOL technologies and maintain a competitive edge.
Recent Developments
- In April 2024, BVI marked
its second market entry in under a year by launching the PODEYE hydrophobic
monofocal intraocular lens (IOL) in Japan, renowned for its hydrophobic lens market.
This new product received approval from the Japanese Pharmaceuticals and
Medical Devices Agency and is now accessible to surgeons and for commercial
use, as announced in a press release. The IOL was introduced at the annual
meeting of the Japanese Ophthalmological Society in Tokyo, Japan, held from
April 18 to 21.
Key Market Players
- Menicon Co., Ltd.
- SEED Co.,
Ltd.
- Toray Industries, Inc.
- Universal View Co., Ltd.
- Alcon Japan Ltd.
|
By Product
|
By Material
|
By End Use
|
By Region
|
- Monofocal IOL
- Multifocal IOL
- Toric IOL
- Accommodative IOL
|
- Polymethylmethacrylate (PMMA)
- Silicone
- Hydrophobic Acrylic
|
- Hospitals
- Ophthalmic Clinics
- Ambulatory Care Centers
- Eye Research Institutes
|
- Hokkaido
- Tohoku
- Kanto
- Chubu
- Kansai
- Chugoku
- Shikoku
- Kyushu
|
Report Scope:
In this report, the Japan Intraocular Lenses Market
has been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
- Japan Intraocular Lenses
Market, By
Product:
o Monofocal IOL
o Multifocal IOL
o Toric IOL
o Accommodative IOL
- Japan Intraocular Lenses
Market, By
Material:
o Polymethylmethacrylate
(PMMA)
o Silicone
o Hydrophobic Acrylic
- Japan Intraocular Lenses
Market, By
End Use:
o Hospitals
o Ophthalmic Clinics
o Ambulatory Care Centers
o Eye Research Institutes
- Japan Intraocular Lenses
Market, By
Region:
o Hokkaido
o Tohoku
o Kanto
o Chubu
o Kansai
o Chugoku
o Shikoku
o Kyushu
Competitive Landscape
Company Profiles: Detailed analysis of the major companies
present in the Japan Intraocular Lenses Market.
Available Customizations:
Japan Intraocular Lenses Market report with
the given market data, TechSci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
Japan Intraocular Lenses Market is an upcoming
report to be released soon. If you wish an early delivery of this report or
want to confirm the date of release, please contact us at [email protected]